Gentile et al. (27) compared the metabolic profiles of lispro and human regular insulin in patients with diet-unresponsive T2D and compensated non-alcoholic liver cirrhosis and found that lispro caused lower postprandial glucose levels and carried a lower hypoglycemia risk. This evidence concerns the gene INS and Hypoglycemia.